Evidence map›Paper›PMID 26751381›Full record

ArticlePloS one2016

LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol.

Mark K Nøhr, Anete Dudele, Morten M Poulsen, Lene H Ebbesen, Yulia Radko, Lars P Christensen, Niels Jessen, Bjørn Richelsen, Sten Lund, Steen B Pedersen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Is the endotoxin-complement cascade the major driver in lipedema?Trends in endocrinology and metabolism: TEM · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mark K NøhrDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Anete DudeleZoophysiology, Department of Bioscience, Aarhus University, Aarhus, Denmark.
Morten M PoulsenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Lene H EbbesenDepartment of Hematology, Aarhus University Hospital, Aarhus, Denmark.
Yulia RadkoDepartment of Chemical Engineering, Biotechnology and Environmental Technology, University of Southern Denmark, Odense, Denmark.
Lars P ChristensenDepartment of Chemical Engineering, Biotechnology and Environmental Technology, University of Southern Denmark, Odense, Denmark.
Niels JessenResearch Laboratory for Biochemical Pathology, Aarhus University Hospital, Aarhus, Denmark.
Bjørn RichelsenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Sten LundDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Steen B PedersenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Aarhus University · DKAarhus University Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledLow-grade inflammation is seen with obesity and is suggested to be a mediator of insulin resistance. The eliciting factor of low-grade inflammation is unknown but increased permeability of gut bacteria-derived lipopolysaccharides (LPS) resulting in endotoxemia could be a candidate. Here we test the effect of LPS and the anti-inflammatory compound resveratrol on glucose homeostasis, insulin levels and inflammation. Mice were subcutaneously implanted with osmotic mini pumps infusing either low-dose LPS or saline for 28 days. Half of the mice were treated with resveratrol delivered through the diet. LPS caused increased inflammation of the liver and adipose tissue (epididymal and subcutaneous) together with enlarged spleens and increased number of leukocytes in the blood. Resveratrol specifically reduced the inflammatory status in epididymal fat (reduced expression of TNFa and Il1b, whereas the increased macrophage infiltration was unaltered) without affecting the other tissues investigated. By LC-MS, we were able to quantitate resveratrol metabolites in epididymal but not subcutaneous adipose tissue. LPS induced insulin resistance as the glucose-stimulated insulin secretion during an oral glucose tolerance test was increased despite similar plasma glucose level resulting in an increase in the insulinogenic index (IGI; delta0-15insulin/delta0-15glucose) from 13.73 to 22.40 pmol/mmol (P < 0.001). This aberration in insulin and glucose homeostasis was normalized by resveratrol. IN

conclusionLow-dose LPS enhanced the glucose-stimulated insulin secretion without affecting the blood glucose suggesting increased insulin resistance. Resveratrol restored LPS-induced alteration of the insulin secretion and demonstrated anti-inflammatory effects specifically in epididymal adipose tissue possibly due to preferential accumulation of resveratrol metabolites pointing towards a possible important involvement of this tissue for the effects on insulin resistance and insulin secretion.

Indexed as

Insulin ResistanceAdipose TissueAnimalsAntioxidantsBlood GlucoseBody WeightEpididymisGene Expression ProfilingGlucoseGlucose Tolerance TestHomeostasisInflammationInsulinInsulin SecretionLeukocytesLipopolysaccharidesAntioxidantsBlood GlucoseGlucoseInsulinLipopolysaccharidesResveratrolStilbenes

Identifiers

PMID26751381
PMCPMC4709071
OpenAlexW2414714594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.